NEUTROPEG pegfilgrastim 6 mg/0.6 mL solution for injection pre-filled syringe

Ülke: Avustralya

Dil: İngilizce

Kaynak: Department of Health (Therapeutic Goods Administration)

Aktif bileşen:

Pegfilgrastim, Quantity: 6 mg

Mevcut itibaren:

Accord Healthcare Pty Ltd

Farmasötik formu:

Injection, solution

Kompozisyon:

Excipient Ingredients: glacial acetic acid; polysorbate 20; sodium hydroxide; sorbitol; water for injections

Uygulama yolu:

Subcutaneous

Paketteki üniteler:

1 prefilled syringe

Reçete türü:

(S4) Prescription Only Medicine

Terapötik endikasyonlar:

For the treatment of cancer patients following chemotherapy, to decrease the duration of severe neutropenia and so reduce the incidence of infection, as manifested by febrile neutropenia.

Ürün özeti:

Visual Identification: clear and colourless liquid; Container Type: Syringe; Container Material: Glass Type I Clear; Container Life Time: 36 Months; Container Temperature: Store at 2 to 8 degrees Celsius; Container Closure: Neither child resistant closure nor restricted flow insert

Yetkilendirme durumu:

Registered

Yetkilendirme tarihi:

2019-08-19